Click here to check out the new plexWell™ SARS-CoV-2 Sequencing application page and get started today with trial kit discounts (50% off).

 

 

 

seqWell was created to revolutionize NGS library prep to unlock the full potential of today’s DNA sequencing instruments.

Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.

In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.

Management

Joseph Mellor, PhD

Founder and Chief Executive Officer

Erick Suh

Chief Commercial Officer

Jack T. Leonard, PhD

Chief Technology Officer

Tom Grant

Chief Financial Officer

Kerri Stellato

Vice President, Sales & Marketing

Chris Boggess

Strategic Consultant; Business Development

Ariele Hanek, PhD

Director, Research and Development

Matt Parisi

Director, Operations

Board of Directors

Paul McEwan

Chairman of the Board

Joe Mellor, PhD

Founder, CEO

Mike Finney, PhD

Board Member

Scientific Advisors

Simone Picelli, PhD

Scientific Advisor

Jason Buenrostro, PhD

Scientific Advisor

Maryke Appel, PhD

Technical Consultant

Interested in joining our team?

We are always looking to add to our team. If you think you’d be a good fit for us, please email us at [email protected] to get in touch with someone about joining our team.